Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT04233398

HIFU Treatment of Benign Thyroid Nodules

A Multi-center, Randomized, Controlled Trial of High Intensity Focused Ultrasound (HIFU) Treatment of Benign Thyroid Nodules

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
240 (estimated)
Sponsor
Theraclion · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

This clinical trial is to evaluate the effectiveness and the safety of high intensity focused ultrasound (HIFU) in the treatment of benign thyroid nodules.

Detailed description

This clinical trial is a prospective, multicentre, randomized, controlled study of high intensity focused ultrasound (HIFU) treatment of benign thyroid nodules. this study will include 240 patients with benign thyroid nodules that meet all ths the inclusion / exclusion criteria and will be randomly divided into two groups at 1: 1 ratio. Patients in the test group will be treated with high intensity focused ultrasound (HIFU), while patients in the control group will be actively observed and followed up by ultrasound examination. The primary objective of this clinical trial is to evaluate the efficacy of the test device in the treatment of benign thyroid nodules, and the secondary objective is to evaluate the safety of the test device in the treatment of benign thyroid nodules and the improvement of symptoms assessed by VAS score.

Conditions

Interventions

TypeNameDescription
DEVICEDevice: Echopulse (HIFU ablation)High-intensity focused ultrasound (HIFU) is a non-invasive, non-invasive treatment method. The principle is to focus high-intensity ultrasound on the target area. Energy is absorbed by the target tissue and converted into thermal energy. The local temperature quickly reaches a maximum of 85 ° C. It induces coagulative necrosis of focus tissue cells, but does not damage the tissues surrounding the treatment targ

Timeline

Start date
2024-08-01
Primary completion
2024-11-01
Completion
2024-11-01
First posted
2020-01-18
Last updated
2024-04-11

Source: ClinicalTrials.gov record NCT04233398. Inclusion in this directory is not an endorsement.